OSU Dermatology Biorepository for donated skin tissue and data
Part of Infections, Skin clinical trials.
This study collects and stores skin samples and related health information from people seen in OSU Dermatology clinics. It helps researchers better understand skin conditions and may lead to new treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an OSU Dermatology visit on the main University Hospital campus (including listed OSU locations) after the study started
- You can give consent yourself, or a parent/legal guardian can consent for a child or someone who can’t consent
- You are willing to participate in a research study
- You are able to provide informed consent (this is required)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people with hidradenitis suppurativa (HS) to better understand the condition over time and store optional health information and samples. Being in the registry may help researchers learn about patterns in HS and support future research.
This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.
This study explores how people with hidradenitis suppurativa (HS) participate in research. You'll report your health regularly using a device, and the goal is to better understand patient experiences.
This study looks at how “stress” inside skin cells may be connected to hidradenitis suppurativa, a long-term painful skin condition with recurrent bumps and tunnels. Your participation may help researchers understand what drives the disease.
This study collects skin samples (like small biopsies or swabs) from people with certain skin conditions and from healthy volunteers. The samples help researchers learn more about these conditions and may lead to better treatments.
This study tracks how secukinumab (a new medication) works for hidradenitis suppurativa—a painful skin condition with recurring boils and abscesses—in real-world patient care in Italy. Researchers want to understand treatment patterns and outcomes to help improve care for this condition.
Hear when a new Hidradenitis Suppurativa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.